pipeline

  1. Thoughts on CV's presentation on March 3?

    https://seekingalpha.com/article/4764210-biogen-inc-biib-ceo-chris-viehbacher-presents-at-td-cowen-45th-annual-health-care-conference especially this part: "We're going to be playing cat and mouse over the next three years with a declining MS franchise and then the new products. So I would say...
  2. A better outlook for 2018 from Lilly

    After raising the quarterly dividend recently, Lilly has provided outlook for 2018 and expects recently launched products to drive revenue. Dave Ricks says ""Looking to the future, the potential of our pipeline remains strong."